Therapeutic inertia in pharmacists who treat people with multiple sclerosis

Takeaway

  • Over 50% of pharmacists who manage people with multiple sclerosis (MS) demonstrate therapeutic inertia (TI).

Why this matters

  • When escalating pharmacotherapy for MS, it is important that pharmacists are involved in encouraging appropriate therapeutic choices.

  • Improving TI may improve clinical outcomes for people with MS.